1. Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis. Issue 11 (13th July 2019) Authors: Liu, Ronghan; Chen, Yuehong; Fu, Wenyu; Wang, Shuya; Cui, Yazhou; Zhao, Xiangli; Lei, Zi-Ning; Hettinghouse, Aubryanna; Liu, Jody; Wang, Chao; Zhang, Chen; Bi, Yufei; Xiao, Guozhi; Chen, Zhe-Sheng; Liu, Chuan-ju Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 11(2019) Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis. Issue 11 (November 2019) Authors: Liu, Ronghan; Chen, Yuehong; Fu, Wenyu; Wang, Shuya; Cui, Yazhou; Zhao, Xiangli; Lei, Zi-Ning; Hettinghouse, Aubryanna; Liu, Jody; Wang, Chao; Zhang, Chen; Bi, Yufei; Xiao, Guozhi; Chen, Zhe-Sheng; Liu, Chuan-ju Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 11(2019) Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗